癌胚性抗原を再検討した.

Same author

ItaLynch: an ongoing Italian study to evaluate the feasibility of mainstreaming the diagnosis of Lynch syndrome in colorectal cancer patients.

ESMO gastrointestinal oncology·2026

Same author

Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Same author

Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic.

Orphanet journal of rare diseases·2020

Same author

Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Same author

The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.

European journal of cancer (Oxford, England : 1990)·2019

Same author

Consensus and controversies regarding follow-up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2018

関連する実験動画

癌胚性抗原を再検討した.

関連する概念動画

ItaLynch: an ongoing Italian study to evaluate the feasibility of mainstreaming the diagnosis of Lynch syndrome in colorectal cancer patients.

Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.

Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic.

Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.

Consensus and controversies regarding follow-up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology.

関連する実験動画

癌胚性抗原を再検討した.

関連する概念動画

ItaLynch: an ongoing Italian study to evaluate the feasibility of mainstreaming the diagnosis of Lynch syndrome in colorectal cancer patients.

Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.

Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic.

Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.

Consensus and controversies regarding follow-up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology.

関連する実験動画

癌胚性抗原を再検討した.

関連する概念動画

関連記事

ItaLynch: an ongoing Italian study to evaluate the feasibility of mainstreaming the diagnosis of Lynch syndrome in colorectal cancer patients.

Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.

Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic.

Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.

Consensus and controversies regarding follow-up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology.

関連する実験動画

癌胚性抗原を再検討した.

関連する概念動画

関連記事

ItaLynch: an ongoing Italian study to evaluate the feasibility of mainstreaming the diagnosis of Lynch syndrome in colorectal cancer patients.

Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.

Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic.

Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.

Consensus and controversies regarding follow-up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology.